These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16697875)

  • 61. [Treatment of muscular layer invasiveness bladder cancer].
    Miyazaki J; Nishiyama H
    Gan To Kagaku Ryoho; 2013 Jan; 40(1):41-6. PubMed ID: 23463895
    [No Abstract]   [Full Text] [Related]  

  • 62. Serum tumor markers may predict overall and disease specific survival in patients with clinically organ confined invasive bladder cancer.
    Margel D; Tal R; Baniel J
    J Urol; 2007 Dec; 178(6):2297-300; discussion 2300-1. PubMed ID: 17936837
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Behavior of urothelial carcinoma with respect to anatomical location.
    Catto JW; Yates DR; Rehman I; Azzouzi AR; Patterson J; Sibony M; Cussenot O; Hamdy FC
    J Urol; 2007 May; 177(5):1715-20. PubMed ID: 17437794
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prognostic factors in stage T1 bladder cancer: tumor pattern (solid or papillary) and vascular invasion more important than depth of invasion.
    Andius P; Johansson SL; Holmäng S
    Urology; 2007 Oct; 70(4):758-62. PubMed ID: 17991551
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Earlier use of aggressive therapy could prevent one-third of bladder cancer deaths.
    Pinkowish MD
    CA Cancer J Clin; 2009; 59(3):142-4. PubMed ID: 19369683
    [No Abstract]   [Full Text] [Related]  

  • 66. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers.
    Novara G; De Marco V; Gottardo F; Dalpiaz O; Bouygues V; Galfano A; Martignoni G; Patard JJ; Artibani W; Ficarra V
    Cancer; 2007 Oct; 110(8):1715-22. PubMed ID: 17724728
    [TBL] [Abstract][Full Text] [Related]  

  • 67. When and how to treat superficial and muscle-invasive bladder cancer.
    Zlotta AR
    Eur Urol; 2007 Dec; 52(6):1554-7. PubMed ID: 17904728
    [No Abstract]   [Full Text] [Related]  

  • 68. Radical cystectomy--often too late? Yes, but ..
    Studer UE
    Eur Urol; 2006 Dec; 50(6):1129-38. PubMed ID: 16949199
    [No Abstract]   [Full Text] [Related]  

  • 69. Editorial comment on: P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors.
    Brausi M
    Eur Urol; 2007 Sep; 52(3):775-6. PubMed ID: 17434253
    [No Abstract]   [Full Text] [Related]  

  • 70. Invasive bladder cancer and uremia: dilemma in management.
    Srinivas V; Nagapurkar N; Choudary R; Kulkarni S; Kundargi P; Phadke AG
    J Urol; 1993 Nov; 150(5 Pt 1):1409-11. PubMed ID: 8411411
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Patterns of questionable quality care in nonmuscle invasive bladder cancer.
    Gore JL; Porter MP
    Cancer; 2010 Jun; 116(11):2508-10. PubMed ID: 20336786
    [No Abstract]   [Full Text] [Related]  

  • 72. Bladder cancer.
    Br Med J (Clin Res Ed); 1981 Mar; 282(6269):1012-3. PubMed ID: 6783224
    [No Abstract]   [Full Text] [Related]  

  • 73. Examining the association between delay in diagnosis and decreased survival in bladder cancer.
    Porter MP
    Cancer; 2010 Nov; 116(22):5122-5. PubMed ID: 20665888
    [No Abstract]   [Full Text] [Related]  

  • 74. Modelling bladder cancer in mice: opportunities and challenges.
    Kobayashi T; Owczarek TB; McKiernan JM; Abate-Shen C
    Nat Rev Cancer; 2015 Jan; 15(1):42-54. PubMed ID: 25533675
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Natural history of bladder tumors].
    Le Duc A
    Pathol Biol (Paris); 1990 Oct; 38(8):795. PubMed ID: 2274359
    [No Abstract]   [Full Text] [Related]  

  • 76. [The prognostic factors in bladder cancer patients].
    al-Shukri SKh; Korneev IA
    Urol Nefrol (Mosk); 1996; (6):49-53. PubMed ID: 9036614
    [No Abstract]   [Full Text] [Related]  

  • 77. Current concepts in the management of patients with deeply invasive bladder carcinoma.
    Cummings KB; Shipley WU; Einstein AB; Cutler SJ
    Semin Oncol; 1979 Jun; 6(2):220-8. PubMed ID: 113879
    [No Abstract]   [Full Text] [Related]  

  • 78. Urologic Clinics of North America. Diagnosis, evaluation, and treatment of non-muscle invasive bladder cancer. Foreword.
    Taneja SS
    Urol Clin North Am; 2013 May; 40(2):xi. PubMed ID: 23540788
    [No Abstract]   [Full Text] [Related]  

  • 79. [The prognosis of bladder tumors].
    Chatelain C; Camey M
    Rev Prat; 1981 Jun; 31(35):2511-2, 2515-9. PubMed ID: 7280527
    [No Abstract]   [Full Text] [Related]  

  • 80. Time to change our approach to high-risk nonmuscle-invasive bladder cancer management in the United Kingdom? Observations from the British Association of Urological Surgeons Cancer Registry.
    Yates DR; Catto JW
    BJU Int; 2010 Sep; 106(5):593-4. PubMed ID: 21105261
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.